AJ

Amar Jeet Singh

Active Director Director DIN 07682966
DIN 07682966 First appointment Dec 2016 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2016
Shareholding value •••• Premium profile

About Amar Jeet Singh

Data last updated:

Amar Jeet Singh is a Director at Mitosis Pharmaceuticals Private Limited (since 2016). The company operates in Business Services. Mitosis Pharmaceuticals Private Limited reported revenue of ₹59,685 (FY 2025).

DIN 07682966
Primary Designation Director
Industry Business Services
First Appointment 21 Dec 2016
Oldest Company Age 9 yrs
Largest company Mitosis Pharmaceuticals Private Limited · ₹59,685 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Dec 20162016₹59,685 (FY 2025)Active

Board colleagues of Amar Jeet Singh

NameDINCompanyDesignation
Gurpreet Kaur08328867Mitosis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mitosis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amar Jeet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amar Jeet Singh

Amar Jeet Singh currently holds 1 directorship: Mitosis Pharmaceuticals Private Limited (Director, since 21 Dec 2016, revenue ₹59,685 (FY 2025)).

Amar Jeet Singh was first appointed on 21 Dec 2016 as Director at Mitosis Pharmaceuticals Private Limited.

The current boards of Amar Jeet Singh's companies include Gurpreet Kaur (Mitosis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available